Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands, Inc. - Common Stock (NQ: TLRY )

0.6093 +0.0193 (+3.27%)
Streaming Delayed Price Updated: 1:16 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Cannabis Giant Tilray Expands Medical Marijuana Portfolio With Redecan Launch In Australia
Tilray Medical announced on Wednesday the launch of Redecan EU-GMP certified medical cannabis products in Australia. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Medical Launches Redecan Cannabis Brand in Australia
EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription 
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Acquires $23.8M Promissory Note In Deal With Double Diamond On Heels Of Brewery Acquisition
Tilray Brands agreed to acquire from DDH a promissory note for $23.8 million payable by 1974568 Ontario Limited. 
Via Benzinga
Our Conservative Cannabis Stock Portfolio Continues To Outperform
Our Conservative Cannabis Stocks Portfolio has outperformed our Canadian Cannabis LP Stocks Portfolio by more than a 3 to 1 margin on an annual basis. As such, our conservative cannabis portfolio is... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
(TLRY) - Analyzing Tilray Brands's Short Interest
Via Benzinga
Marijuana Stock Movers For September 16, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
This European Country Could Lose $242M A Year If It Doesn't Regulate Its Marijuana Market, Study Finds
The Czech Republic could be missing out on hundreds of millions of euros annually as the governing coalition remains persistent in avoiding establishing a regulated marijuana market. That's according... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis LP Stocks Were +6% Last Week Vs. -10% The Previous Week
The Canadian Cannabis LP Stocks Portfolio was up +6% last week from a 10% decline w/e Sept. 6th as the negative sentiment waned surrounding the DEA's announcement that it would be having a December 2nd... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Billion-Dollar Marijuana Giant Buys Another Brewery From Molson Coors, Expands Great Lakes Footprint
Tilray Brands acquires Atwater Brewery from Molson Coors, expanding reach in Great Lakes region and strengthening position in craft beer industry. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company
From Tilray Brands, Inc.
Via GlobeNewswire
Breckenridge Brewery Unveils Oktoberfest Brew and Hosts 28th Annual Oktoberfest Festival: A Weekend of Live Music, Traditional German Cuisine, and Tasty Brews in Breckenridge, Colorado
From Tilray Brands, Inc.
Via GlobeNewswire
Last Call For SNDL's Liquor President: Stock On The Rocks Amid Leadership Changes
Taranvir "Tank" Vander, President of its Liquor Division, is stepping down. On Tuesday, SNDL experienced a slight dip in its price. 
Via Benzinga
Cannabis Flower? No, Thanks: Canadians Shift To Pre-Rolls & Vapes As Market Eyes C$5.47B
The Canadian cannabis market is shifting towards newer product formats, with some segments outperforming cannabis flowers in sales. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Canadian Cannabis LP Stocks Portfolio -10% W/e Sept. 6th
Our LP portfolio was down 10% last week as a result of the August 26th announcement by the DEA that it had scheduled an administrative hearing for December 2nd to consider differing expert opinions on... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For September 9, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds
Tilray Medical, a division of Canadian cannabis giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday a new scientific publication supported by Tilray Medical titled, Treatment in... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
From Tilray Brands, Inc.
Via GlobeNewswire
Data Shows More Consumers Opting for Sustainably Manufactured Cannabis Products
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Our Conservative "Cannabis" Portfolio Performed Better In August (and YTD) Than Either OUR MSO Or LP Portfolios
If you are wary of the volatility of cannabis stocks then consider the 5 tobacco, beer, and distiller/vintner companies that have major investments in the cannabis sector. Their stock returns... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
Stocks in the cannabis sector showed varied reactions on Wednesday, after Trump's comments on the legalization of marijuana in Florida. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
420 with CNW — NIH Study Finds Concurrent Use of Tobacco, Marijuana Is Rising
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Billion-Dollar Cannabis Company Closes Acquisition Of Three US Breweries, What's Next For Tilray
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company
From Tilray Brands, Inc.
Via GlobeNewswire
Largest Cannabis Stocks Are Down +10% In Last Two Days: Here's Why
The American Cannabis MSO Portfolio is DOWN 13.2% in the past 2 days and is now DOWN 18.4% MTD (and DOWN 5.9% YTD). 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Canopy Growth's CEO Is Leaving: Is That a Sign of Trouble for the Cannabis Stock?
A change in CEO could help Canopy Growth pivot away from a costly strategy focused on the U.S. pot market. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 27, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 New Reasons to Consider Buying Tilray Brands Stock in 2024
Its strategic ambitions for its beer business are quickly becoming a reality. 
Via The Motley Fool
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
The cannabis company on Nasdaq has partnered with Vectura Fertin Pharma, to launch a dissolvable tablet that delivers a precise dose of CBD. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.